A Rockville biotechnology company received a patent and some key designations for a cancer drug candidate.
Tagged with: GlycoMimetics Inc.Read More »
February 4, 2020 Leave a comment
January 30, 2020 Leave a comment
January 7, 2020 Leave a comment
August 5, 2019 Leave a comment
July 6, 2017 Leave a comment
A Maryland biotechnology company focused on cancer and sickle cell disease is set to receive a patent in Europe. The European Patent Office told GlycoMimetics Inc., which is based in Rockville, that it plans to grant a patent related to its ...Read More »